ClinVar Miner

Submissions for variant NM_000057.4(BLM):c.3163T>C (p.Cys1055Arg)

gnomAD frequency: 0.00001  dbSNP: rs746218707
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000664476 SCV000788439 uncertain significance Bloom syndrome 2017-12-24 criteria provided, single submitter clinical testing
Ambry Genetics RCV002325337 SCV002608498 likely pathogenic Hereditary cancer-predisposing syndrome 2021-10-22 criteria provided, single submitter clinical testing The p.C1055R variant (also known as c.3163T>C), located in coding exon 15 of the BLM gene, results from a T to C substitution at nucleotide position 3163. The cysteine at codon 1055 is replaced by arginine, an amino acid with highly dissimilar properties. This alteration has been identified in one patient with Bloom syndrome who also carried c.2098C>T (German J et al. Hum Mutat, 2007 Aug;28:743-53). Another alteration at the same codon, p.C1055S (c.3164G>C), has been reported in the literature in both a homozygous and compound heterozygous state in individuals with Bloom syndrome (Ellis NA et al. Cell, 1995 Nov;83:655-66; German J et al. Hum. Mutat., 2007 Aug;28:743-53; Montenegro MM et al. Mol Genet Genomic Med, 2020 04;8:e1133). Functional studies of p.C1055S have also demonstrated that this alteration causes reduced BLM protein expression and lacks detectable helicase and DNA-dependent ATPase activities, which are essential for wild-type interaction of BLM with tp53 in the DNA damage response pathway (Wang XW et al. J. Biol. Chem., 2001 Aug;276:32948-55; Neff NF et al. Mol. Biol. Cell, 1999 Mar;10:665-76). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, this variant is likely to be pathogenic.
Baylor Genetics RCV000664476 SCV004210917 likely pathogenic Bloom syndrome 2023-03-07 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.